membraanflap

A membraanflap, also known as a membrane flap, is a surgical procedure used to correct a defect in the heart's left atrium, a chamber that receives oxygenated blood from the lungs. This procedure is typically performed in infants and children who have a condition called atrial septal defect (ASD), where there is an opening between the left and right atria.

The membraanflap procedure involves creating a small, artificial flap from the patient's pericardium, the sac that surrounds the heart. This flap is then sutured to the atrial septum, the wall that separates the left and right atria, to close the defect. The goal of the procedure is to prevent blood from flowing backward from the left atrium to the right atrium, which can lead to volume overload and heart failure.

The membraanflap procedure is considered a less invasive alternative to other ASD closure techniques, such as the Mustard or Senning procedures. It is typically performed using cardiopulmonary bypass, a method that temporarily takes over the heart and lungs to provide oxygen and nutrients to the body during surgery. The procedure is usually followed by a short hospital stay, and most patients can return to their normal activities within a few weeks.

The success rate of the membraanflap procedure is generally high, with most patients experiencing a significant improvement in their symptoms and overall health. However, like any surgical procedure, it carries risks, including infection, bleeding, and damage to nearby structures. As with any medical procedure, the decision to undergo a membraanflap should be made in consultation with a healthcare provider, taking into account the patient's individual circumstances and medical history.